Quantumlife Sciences Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
as on 16-11-2024
- Paid Up Capital ₹ 3.00 M
as on 16-11-2024
- Company Age 9 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -16.63%
(FY 2023)
- Profit -557.57%
(FY 2023)
- Ebitda -226.66%
(FY 2023)
- Net Worth -21.68%
(FY 2023)
- Total Assets -11.64%
(FY 2023)
About Quantumlife Sciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 3.00 M, as per Ministry of Corporate Affairs (MCA) records.
Kartikeya Sharma, Narendra Ahuja, Hemendra Singh, and Three other members serve as directors at the Company.
- CIN/LLPIN
U51101UP2015PTC071447
- Company No.
071447
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jun 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Quantumlife Sciences?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kartikeya Sharma  | Director | 18-Jun-2015 | Current |
| Narendra Ahuja | Director | 18-Jun-2015 | Current |
| Hemendra Singh | Director | 18-Jun-2015 | Current |
| Deepak Sharma | Director | 18-Jun-2015 | Current |
| Yuganter Pandey | Director | 20-Aug-2024 | Current |
| Ruchi Tandon | Director | 20-Aug-2024 | Current |
Financial Performance of Quantumlife Sciences.
Quantumlife Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 16.63% decrease. The company also saw a substantial fall in profitability, with a 557.57% decrease in profit. The company's net worth observed a substantial decline by a decrease of 21.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Quantumlife Sciences?
In 2023, Quantumlife Sciences had a promoter holding of 30.00% and a public holding of 70.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Quantumlife Sciences?
Unlock and access historical data on people associated with Quantumlife Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Quantumlife Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Quantumlife Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
